SLC22A3 and malignant colon neoplasm: In line with this, the same group also demonstrated in in vitro and in vivo experimental systems that the cellular concentration of oxaliplatin and its cytotoxicity were significantly increased in response to high expression of OCT3, whereas OCT3 knockdown directly increased the invasion and migration of colon cancer cells.